Filter
349
Filtered Results: 349
Text search:
GMP
Featured
Recommendations
41
New Publications
102
Language
Document type
No document type
175
Guidelines
67
Studies & Reports
46
Manuals
30
Strategic & Response Plan
13
Fact sheets
8
Training Material
6
Situation Updates
4
Countries / Regions
India
17
Nepal
14
Kenya
14
Ethiopia
13
Uganda
10
Sierra Leone
9
Nigeria
9
Global
9
Zambia
9
Tanzania
8
South Africa
7
Namibia
7
Liberia
7
Ghana
6
Western and Central Europe
6
Zimbabwe
5
Bangladesh
5
Africa
4
Germany
4
Middle East and North Africa
4
Botswana
4
Indonesia
4
Rwanda
3
Philippines
3
Latin America and the Carribbean
3
South–East Asia Region
3
Russia
3
South Sudan
3
Tajikistan
2
Colombia
2
Syria
2
Senegal
2
Malawi
2
Eastern Europe and Central Asia
2
Eastern Europe
2
Brazil
2
Yemen
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Thailand
1
Ukraine
1
Lesotho
1
Cameroon
1
Iran
1
Albania
1
Laos
1
Burkina Faso
1
Guinea
1
Mozambique
1
Cambodia
1
Guinea-Bissau
1
Jordan
1
Congo, Democratic Republic of
1
West and Central Africa
1
Western Pacific Region
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Spain
1
East and Southern Africa
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Sri Lanka
1
Mali
1
Angola
1
Bhutan
1
Somalia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
161
Clinical Guidelines
48
Public Health
25
Pharmacy & Technologies
25
Capacity Building
11
Women & Child Health
11
Key Resources
11
Toolboxes
Pharmacy
40
AMR
36
COVID-19
25
Planetary Health
15
TB
14
Rapid Response
8
NTDs
8
Ebola
7
Refugee
4
Zika
4
Global Health Education
4
Natural Hazards
3
HIV
2
Conflict
2
Cholera
1
Caregiver
1
Health Financing Toolbox
1
NCDs
1
Polio
1
These guidelines have been developed to provide guidance to the Ministry of Health in managing applications for registration of human pharmaceutical products in Rwanda. It was compiled by the Technical Working Group (TWG) on Medicines Evaluation and Registration (MER) of the East African Community M...
PQM conducted an assessment of the medicine quality assurance and quality control systems in Rwanda during November 9-13, 2009. Medicine quality assurance remains to be developed in Rwanda: the country has neither a medicine regulatory authority (MRA) nor a national medicine quality control laborato...
The document contains a set of indicators that can be used for monitoring traditional and complementary medicine (T&CM) systems in a country.
The core indicator set consists of 16 indicators that were considered essential and collectively able to provide information on T&CM inputs, processes and ou...
Effective malaria prevention is threatened by widespread and increasing vector insecticide resistance. Failure to mitigate this threat will likely result in an increased burden of disease, with significant cost implications. This new framework provides support for the development of a national insec...
L’ampleur de la résistance aux insecticides chez les vecteurs du paludisme met en péril l’efficacité des programmes de lutte anti-vectorielle. Si cette résistance n’est pas atténuée, le taux de morbidité palustre va s’accroître, entraînant une hausse significative des coûts liés ...
The guidelines reiterate that the general principles of ethics for biomedical research involving human participants shall also be applicable. In addition, the guidelines specify unique provisions for stem cells, because of their inherent property for unlimited proliferation, differentiation to cells...
This report presents the findings from the Community Based Volunteers Skill Audit Survey that was carried out in 11 districts in Zambia as part of the Millennium Development Goal Acceleration Initiative.
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
This document outlines the evaluation process that WHO undertakes to assess novel tools and strategies targeted at VBDs. Its aim is to articulate the linkage between the generation of evidence that demonstrates public health impact of novel interventions, and the development of policy recommendation...
Taking the whole of Africa approach to fighting the COVID-19 pandemic has and will continue to require coordinated efforts from multiple stakeholders from across the continent. Africa CDC would like to acknowledge the deep partnership and continued support of AUDA-NEPAD, AVAREF, WHO AFRO, the Bill a...
The community-BFCI (c-BFCI) manual has been developed to facilitate training of CHVs and stakeholders providing nutrition sensitive services at community level. The manual covers a wide range of topics: basic nutrition, exclusive breastfeeding, complementary feeding, Breast Milk Substitutes Act, gro...
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’.
The guidance should be read alon...
Annex 5, WHO Technical Report Series 1010, 2018
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
Government of Nepal has an obligation to ensure availability of affordable and high quality basic health care services to its population
